Overexpression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in human cutaneous malignant melanoma

Journal of Cutaneous Pathology

Volumn 24, Issue 5, 1997, Pages 265-271

  Trotter, Martin J ^a,b   Tang, Liren ^a   Tron, Victor A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOMA; METASTASIS; MITOSIS; PROTEIN EXPRESSION; STAINING; TUMOR GROWTH;

BLOTTING, WESTERN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; NEOPLASM METASTASIS; SKIN NEOPLASMS;

EID: 0030958766     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1997.tb00790.x     Document Type: Article

References (46)

1. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994: 16: 1821.
2. Kamb A. Cell-cycle regulators and cancer. Trends Genet 1995: 11: 137.
3. Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995: 11: 211.
4. Hunter T. Braking the cycle. Cell 1993: 75: 839.
5. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993: 75: 805.
6. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993: 366: 701.
7. Gu Y, Turck CW, Morgan DO. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 1993: 366: 707.
8. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993: 75: 817.
9. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994: 211: 90.
10. Jiang H, Lin J, Su Z, et al. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 1995: 10: 1855.
11. Shiohara M, El-Deiry WS, Wada M, et al. Absence of WAF1 mutations in a variety of human malignancies. Blood 1994: 84: 3781.
12. Li Y-P, Laurent-Puig P, Salmon RJ, Thomas G, Hamelin R. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene 1995: 10: 599.
13. Vidal MJ, Loganzo F Jr, de Oliviera AR, Hayward NK, Albino AP. Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas. Melanoma Res 1995: 5: 243.
14. Weiss J, Heine M, Arden KC, et al. Mutation and expression of TP53 in malignant melanomas. Recent Results Cancer Res 1995: 139: 137.
15. Li G, Ho VC, Trotter MJ, Horseman DE, Tron VA. p53 mutation in metastatic melanomas and primary melanomas from sun-exposed and sun-protected sites. J Eur Acad Dermatol Venereol 1995: 4: 48.
16. Cip1 in muscle and other terminally differentiating cells. Science 1995: 267: 1024.
17. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994: 54: 3391.
18. Jiang H, Lin J, Su Z, Collart FR, Huberman E, Fisher PB. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 1994: 9: 3397.
19. Missero C, Calautti E, Eckner R, et al. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 1995: 92: 5451.
20. Steinman RA, Hoffman B, Iro, A, Guillouf C, Liebermann DA, El-Houseini ME. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 1994: 9: 3389.
21. Bond JA, Blaydes JP, Rowson J, et al. Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1. Cancer Res 1995: 55: 2404.
22. sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts. Oncogene 1995: 10: 835.
23. Sheikh MS, Li X-S, Chen J-C, Shao Z-H, Ordonez JV, Fontana JA. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 1994: 9: 3407.
24. Pontén F, Berne B, Ren Z-P, Nistér M, Pontén J. Ultraviolet light induces expression of p53 and p21 in human skin: effect of sunscreen and constitutive p21 expression in skin appendages. J Invest Dermatol 1995: 105: 402.
25. Li M, Pelling JC. UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAF1/CIP1 expression. Oncogene 1995: 10: 1955.
26. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang X-F. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995: 92: 5545.
27. Yang Z-H, Perkins ND, Ohno T, Nabel EG, Nabel GJ. The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nature Med 1995: 1: 1052.
28. Barnhill RL, Roush GC, Duray PH. Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi. Hum Pathol 1990: 21: 51.
29. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 1995: 55: 2910.
30. Cattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwaved-processed formalin-fixed paraffin sections. J Pathol 1992: 168: 357.
31. Godfrey K. Comparing the means of several groups. N Engl J Med 1985: 313: 1450.
32. WAF1. Cancer Res 1995: 55: 4536.
33. Zhang H, Xiong Y, Beach D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 1993: 4: 897.
34. Li Y, Jenkins CW, Nichols MA, Xiong Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 1994: 9: 2261.
35. Wang Y, Becker D Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system. Oncogene 1996: 12: 1069.
36. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989: 49: 6449.
37. Chedid M, Michieli P, Lengel C, Huppi K, Givol D. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Oncogene 1994: 9: 3021.
38. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995: 269: 1281.
39. Reed JA, Loganzo F Jr, Shea CR. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 1995: 55: 2713.
40. WAF1/CIP1/SDI1. Oncogene 1995: 11: 1409.
41. Chen X, Bargonetti J, Prives C. p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res 1995: 55: 4257.
42. Zhang H, Hannon GJ, Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 1994: 8: 1750.
43. Saenz-Santamaría MC, McNutt NS, Shea CR. Immunohistochemical expression of retinoblastoma protein in cutaneous melanomas. Br J Dermatol 1995: 133: 890.
44. Baringa M. A new twist to the cell cycle. Science 1995: 269: 631.
45. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994: 79: 13.
46. Pagano M, Tam SW, Theodoras AM, et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995: 269: 682.